The Dark Side of NK Cells in Cancer Immunotherapy

Felipe Galvez-Cancino1, Maria Armero1, David R Withers2

  • 1Laboratory of Immune-Regulation, Centre for Immuno-Oncology, Nuffield Department of Medicine, Oxford, United Kingdom.

Cancer Discovery
|September 4, 2025
PubMed

Insights

Natural killer (NK) cells can hinder cancer immunotherapy. These immune cells, while cytotoxic, may impair the effectiveness of immune checkpoint blockade through regulatory mechanisms.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Biology

Background:

  • Natural killer (NK) cells are innate lymphoid cells known for their cytotoxic activity against transformed cells in mice and humans.
  • NK cell infiltration into tumors is a recognized phenomenon in cancer biology.

Purpose of the Study:

  • To investigate the role of NK cell infiltration in the efficacy of immune checkpoint blockade therapies.
  • To elucidate the immune-regulatory mechanisms by which NK cells may impact cancer treatment outcomes.

Main Methods:

  • Analysis of NK cell infiltration in tumor microenvironments.
  • Assessment of NK cell function in the context of immune checkpoint blockade.
  • Investigation of immune-regulatory pathways involving NK cells.

Main Results:

  • NK cell infiltration is not universally beneficial in cancer.
  • Tumor-infiltrating NK cells can negatively regulate the anti-tumor immune response.
  • NK cells can impair the efficacy of immune checkpoint blockade treatments.

Conclusions:

  • The role of NK cells in cancer immunity is complex and context-dependent.
  • NK cell infiltration can be detrimental to the success of immune checkpoint blockade.
  • Targeting NK cell regulatory functions may represent a novel therapeutic strategy in oncology.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
2.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K